Publication | Open Access

Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial

Inflammationβ-Cell FunctionDiabetes ManagementAnti-interleukin-21 AntibodyDiabetesImmunologyDiabetes MellitusImmunotherapyMedicineRecent-onset Type 1